What is Upstream Bio, Inc.'s other current liabilities?

Upstream Bio, Inc. (UPB) reported other current liabilities of $1.23M in Q1 2026.

How has Upstream Bio, Inc.'s other current liabilities changed year-over-year?

Upstream Bio, Inc.'s other current liabilities increased by 166.4% year-over-year, from -$1.85M to $1.23M.

Upstream Bio, Inc. UPB Other Current Liabilities

Other Current Liabilities at other companies

Avalo TherapeuticsAVTX

——

Other financials

Income statement

See full

Revenue$1.0M+82.7%

Operating income-$43.6M-36.2%

Net income-$40.6M-48.8%

EPS (diluted)-$0.75-47.1%

Balance sheet

See full

Cash & equivalents$96.7M+35.6%

Total debt$1.1M-34.5%

Total equity$304.0M-31.8%

Total assets$318.1M-30.3%

Cash flow

See full

Operating cash flow-$47.9M-16.2%

CapEx$54.0K-70.8%

Free cash flow-$30.7M-55.0%

Valuation

See full

Market cap$346.11M-40.9%

Enterprise value$250.5M-51.4%

P/S104.2×-151×

Profitability

See full

Operating margin-5,176.5%+1,764pp

Net margin-4,719%+2,752pp

Returns & leverage

See full

Return on equity-41.8%—

Debt / equity0×0.0×

Current ratio23.1×-24.3×

Where this comes from

Reported directly by Upstream Bio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities.

The official record: Upstream Bio, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Upstream Bio, Inc.'s other current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Upstream Bio, Inc.'s other current liabilities?: Upstream Bio, Inc. (UPB) reported other current liabilities of $1.23M in Q1 2026.
How has Upstream Bio, Inc.'s other current liabilities changed year-over-year?: Upstream Bio, Inc.'s other current liabilities increased by 166.4% year-over-year, from -$1.85M to $1.23M.